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It  has  been  known  for a  long  time  (4,  6)  that  high  pressures  coagulate 
proteins.  Lauffer and Dow (13)  recently described in some detail  the dena- 
tnring  effects of pressure on tobacco mosaic virus.  So far as known  to  the 
present author,  only one experiment has been made on an antibody at high 
pressure  (1).  Basset and  Macheboeuf  (1)  reported  that  considerable  anti- 
toxic activity remained in a horse antitoxin which had been kept at a pressure 
of 13,500 atmospheres for 45 minutes.  The quantitative  significance  of this 
result is obscured, however, by the fact that  water at  room temperature  is 
frozen at this pressure (5). 
Treatment  of antibody in various ways may alter its activity (il,  19, 23), 
and in some experiments such altered antibody seemed to develop an inhibiting 
activity (19).  That is, the antibody after the treatment would still combine 
with its antigen, but without bringing about its characteristic "second phase" 
effects (precipitation, agglutination, etc.), and its combination with the antigen 
prevented  the  subsequent  production,  by ordinary  untreated  antibody,  of 
such second phase effects with this antigen. 
Such inhibiting  antibodies are sometimes met with in antisera  which have 
not been subjected to any unusual treatment  (8, 18, 21, 14), but their nature 
is still not fully understood, as witness the observation of Jones and Orcutt 
(12)  that addition of an inhibiting  antibacterial agglutinating  serum did not 
measurably add to the volume of agglutinated bacteria, whereas the agglutinin 
itself produced a marked increase over the original  (unagglutinated)  volume. 
Therefore, it seemed of interest to study the effect of high pressures on agglu- 
tinating and inhibiting antibodies. 
EX:PE~IMENTAL 
Professor P. W. Bridgman very kindly consented to apply various pressures to the sera 
stud~ed, using methods and apparatus essentially the same as those devised by him a number 
of years ago  (of.  5).  Since there seemed considerable likelihood that a  ]ipoid solvent, such 
as  the kerosene which is usually used as the liquid to  transmit pressure, would alter the 
behavior of the serum, especially if allowed to come in contact with it at high pressure, the 
pressure was applied to the serum through metallic mercury, and the pressure was applied 
to the mercury through kerosene.  Even so, it cannot be stated positively that the mercury, 
or the steel wails of the container, played absolutely no rble in the effects observed.  It seems 
likely that pressure was the main factor, however.  The serum was kept at  the pressure 
selected for 24 hours at room temperature (ca.  25  °  ) unless otherwise mentioned. 
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Three  different kinds of  hemagglutinating sera  were  investigated;  (a)  human anti-A 
(and anti-B) agglutinating sera,  some of which came from "stimulated" donors (22),  and 
were thus much stronger than those from untreated individuals  selected at random, (b) anti-Rh 
sera,  and (c) anti-Rh "blocking" sera (18, 20). 
After the sera were removed from the pressure apparatus, they were  compared in serial 
dilutions with the untreated serum, if they were still liquid after pressure treatment.  At pres- 
sures in the higher part of the range examined, the sera were partly coagulated.  These sera 
were mixed with an equal volume of physiological saline, shaken vigorously, and filtered. 
Except at the highest pressures studied, this procedure was sufficient to dissolve the gel,  or 
at least to reduce its particles to such a size that they would pass through filter paper.  These 
mixtures were then tested in serial dilutions against the proper antigens. 
The treated sera were also  tested for inhibiting activity in the following  way: one drop 
of the treated serum (or some dilution of it)" was added to one drop of the appropriate cell 
TABLE I 
Titer (Last Dilution Showing Activity)  of IsoSmmune Anti-A Serum, before and after Exposure 
to Various Pressures for 24 Hours 
One per cent cell suspensions used, 
Pressure 
arm. 
10,000 
7,000 
5,000 
4,000 
3,000 
3,000" 
0t 
Ax cells 
Titer 
0 
0 
0 
8 
512 
32 
2048 
A2B cells 
0 
0 
0 
0 
128 
64 
2048 
* Kept at 3,000 atmospheres for 48 hours. 
Atmospheric pressure. 
suspension (group A1 or A2B in the case of the anti-A, type ORb0 in the case of anti-Rh). 
This mixture was incubated at 37  ° for  1 hour, centrifuged at low speed,  and shaken gently 
to  see whether agglutination was present.  After this reading the tubes were  centrifuged 
again, the supernatant removed, and good, but not too strong, untreated serum of the appro- 
priate type (anti-A or anti-Rh0) was added.  The final readings were  made, in the case of 
anti-A, by mixing, centrifuging, and shaking.  In the case of anti-Rh the final mixture was 
first incubated for 1 hour, then shaken gently, and read. 
RESULTS 
It was found, as expected,  that pressures of the order of magnitude which 
have  previously been found  to  coagulate  proteins  would destroy  the  anti-A 
agglutinins investigated.  The  experiments  are  summarized  in Table  I.  It 
will be seen that destruction is complete at pressures above 4,000 atmospheres, 
and the results suggest that long enough exposure to even 3,000 atmospheres 
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strength  of reaction  in  the  various  tubes  it  was  estlmsted  that  the  serum 
which had been kept at 4,000 atmospheres for 24 hours had less than  1 per 
cent of its original agglutinin activity for AI erythrocytes, and no detectable 
activity for A~B  cells.  The serum kept at 3,000 atmospheres for 24 hours 
seemed to have about 25 per cent of its anti-A1 agglutinin content and about 
2 to 6  per cent of the antibodies active against  A2B.  Serum kept at 3,000 
atmospheres for 48 hours showed an even greater destruction of antibody. 
Pressure-treated sera which showed little or no anti-A activity were tested, 
at various dilutions, for inhibiting activity, using the technic described above. 
In no case was any inhibition found, suggesting that the process of destruction 
of anti-A by pressure does not go  through a  stage of "univalent" antibody 
TABLE II 
Times of Agglutination on Open Slides (Rocked by Hand) of Untreated and Pmssure-Treaed 
Sera 
Ten per cent cell suspensions were used. 
A~ cells  A2B cells 
Pressure 
,I  c  I  C 
a|m, 
0 
3,000 
4,000 
5,000 
7,00o 
10,000 
SeC. 
5 
5 
25 
sec. 
30 
15 
65 
SeC. 
5 
5 
strc. 
2O 
15 
The symbol I  stands for initial agglutination, or in other words, the first agglutination 
visible  to  the  naked  eye.  C  stands  for  "complete" agglutination  (3).  The  symbol -- 
indicates that no agglutination was seen within the period of observation (3 minutes). 
(21)  which  can  combine  with  cells  but  does  not  agglutinate  them.  This 
agrees with what was found during a study of the destruction of anti-A agglu- 
tinin by photo-oxidation (3). 
Not only were the titers of the various specimens examined, but the rates 
of agglutination on open slides,  which have been used as a  measure  of the 
quality of antibody somewhat loosely termed "avidity" (2) were tested.  The 
results are shown in Table II.  It will be seen that the rate of agglutination 
of the serum exposed to a  pressure of 4,000 atmospheres had been definitely 
decreased, and that higher pressures completely inactivated the serum. 
It was of some interest to examine ultracentrifugally one of the specimens 
which  was  nearly  inactivated,  to  determine  whether  there  had  been  any 
change in the state of aggregation of the proteins present.  Dr. J. L. Oncley 
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to a  pressure of 4,000  atmospheres, and on an untreated specimen for com- 
parison.  ~It was found that while the untreated serum showed components 
with sedimentation constants in the vicinity of 4, 7, and 20 svedbergs (16)  in 
amounts amounting  (in  percentages  of  total protein  present)  to  about  86, 
12, and 2 respectively,  1 the pressure-treated material showed components with 
ill defined sedimentation constants of over 20,  amounting to  about 50 per 
cent of the material.  These components were quite heterogeneous.  It was 
clear that a good deal of polymerization had taken place, as might have been 
expected.  This should be borne in mind in interpreting the results obtained 
with Rh agglutinating and blocking antibodies, to be described further on in 
this paper. 
In spite of the polymerization, however, and demonstrable loss of antibody 
activity, the proteins of the  treated serum were not completely inactivated 
serologically, even at  10,000 atmospheres,  for it was found that all of the 
treated  sera,  like  the untreated,  reacted up  to  a  dilution of about  1:1,000 
with a rabbit anti-human serum (which was at the time the only one available). 
When an anti-Rh0 agglutinating serum (of human origin) was exposed to a 
pressure  of  3,000  atmospheres  for  24  hours,  considerable  anti-Rh  activity 
remained.  Tests also  showed that anfi-A and anti-B  agglutinins were also 
still present (the anti-Rh serum was from a  group O  individual).  Exposure 
of another sample of the same serum to a  pressure of 4,500  atmospheres for 
24 hours destroyed all anti-Rh activity and all anti-A and anti-B  activity, 
as would have been anticipated  (see  Table  I).  No  inhibiting  ("blocking") 
activity for anti-Rh0  or for anti-A or anti-B  was developed, again in  con- 
formity with previous results. 
The next serum examined was a  group A  serum which contained a  very 
potent  "blocking"  (18,  20)  antibody for anti-Rh0.  After exposure  of  this 
serum to a pressure of 4,500 atmospheres for 24 hours, it was found that the 
anti-B agglutinin originally present had been destroyed, as expected, and no 
"blocking" activity for anti-B  agglutinins had developed.  The  "blocking" 
activity for anti-Rh0 agglutinins, however, was unimpaired, as could he shown 
by testing the serum as an anti-Rh0 inhibitor, as described above, or by titrating 
it against ORh0 cells suspended in a 20 per cent albumin solution (7, 9).  The 
titer  as  determined  in  this  way  was  1,024, both  before and after pressure 
treatment. 
The group A serum containing this potent "blocker" for anti-Rh0 was next 
put under a  pressure of between 5,000  and 5,500  atmospheres for 24 hours. 
Under this treatment the serum coagulated, and a  good deal of material did 
not resuspend or go into solution when the sample was shaken with an equal 
1  These solutions were studied at about 45 per cent of the concentration of normal protein, 
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volume of saline in the usual way.  It was obviously impossible  to carry out 
tests for agglutinating activity on the insoluble material, so this was centrifuged 
off in the usual laboratory centrifuge, and tests performed on the supernatant. 
These tests revealed that no activity which seemed connected with hemagglu- 
tinating power remained.  There was no agglutinating activity for erythrocytes 
of group B  or for type ORh0, and no "blocking" activity for either of these 
factors was found, by either of the two methods mentioned above.  It was 
apparent  that  the  "critical pressure"  of  the  "blocking"  anti-Rh0  had  been 
found and  that  it  lies in  the region  between 4,500  and  5,500  atmospheres. 
Without  going  to  considerable  trouble  (in  calibrating  the  pressure  gauge, 
etc.),  it  would be  difficult  to  estimate  this  "critical pressure"  much  more 
exactly, and  in  the absence of assurance  that  all such sera behave alike,  it 
seemed hardly worth while. 
DISCUSSION 
The most interesting part of these results, it seems,  is the demonstration 
that  a  definitely higher  pressure  is required  to  destroy anti-Rh  "blocking" 
antibody  than  is required.for  anti-Rh  agglutinating  antibody,  or anti-A  or 
anti-B agglutinins.  This agrees with previous opinions (10) that the "block- 
ing" antibody differs, especially in regard to stability, from the agglutinating 
antibody.  The nature  of this difference  is still  not clear,  in the opinion of 
the present writer. 
It has been proposed (21) that the "blocking" antibody for anti-Rh differs 
from the agglutinating  antibody in  being univalent  instead  of bivalent  (or 
multivalent).  This is probably believed by some to be the general explanation 
of  the  behavior  of  inhibiting  antibodies.  Since  the  "blocking"  antibody 
appears  usually after agglutinating  antibodies  have developed, it  might  be 
thought  that  the  "blocker"  represents  a  fragment,  with  only  one  specific 
combining  group,  of  the  "complete,"  or  agglutinating,  antibody.  Such  a 
concept clearly underlies the reasoning of workers such  as Tyler (19)  (cf. 3), 
who found that drastic treatment, by various means, seemed to result in the 
conversion of active antibody into inhibiting antibody.  The present results, 
however, do not seem to lend  this hypothesis much  support,  for the ultra- 
centrifuge study indicates that the effect of high pressure on plasma proteins 
is on the whole not to break up the molecules,  but to induce polymerization. 
If  interconversion  between  agglutinating  anti-Rh  and  "blocking"  anti-Rh 
were possible, it might be thought that pressure would result in the conversion 
of some "blocking" antibody into agglutinating antibody, by the polymeriza- 
tion of two (or more) univalent antibody molecules into a divalent (or poly- 
valent)  molecule capable of causing agglutination.  This,  however, did not 
seem to occur.  It seems,  therefore,  that  the question of the relationship  of 406  HIGH PRESSURES  AND  IcI:EMAGGLUTINATIIqG  ANTIBODIES 
agglutinating and "blocking" antibody in the Rh system, and perhaps of the 
relationship of active and  inhibiting antibody in  general, is  still open.  In 
the cases in which an inhibiting antibody seemed to develop following treat- 
ment which destroyed the active antibody (cf. 3) there may be the possibility 
that the inhibiting antibody was already present,  and its activity was only 
disclosed when the active antibody was destroyed (10).  This is all the more 
probable since the inhibiting antibody is more stable than the active antibody. 
There is still no certainty that one can be converted into the other, and treat- 
ments,  such  as  exposure  to  high  pressures  as  just  described,  which  might 
conceivably have resulted in such transformation, have failed to do so. 
I wish to thank Professor P. W. Bridgman and his assistants for applying the various 
pressures to the antisera studied and Dr. J. L. Oncley for examining one of our treated 
sera in the ultracentrifuge.  I am also indebted to Dr. L. K. Diamond for generously 
supplying the anti-Rh and anti-Rh "blocking" sera used.  Thanks are due to EsteUe 
Warshaver for technical assistance.  This work was aided by a grant from The Rocke- 
feller Foundation. 
SUMMARY 
It was found that exposure of hemagglutinating sera  to pressures of the 
order of 3,000  to 4,000  atmospheres destroyed their agglutinating power, but 
did not convert them to inhibiting ("blocking") antibodies.  Higher pressures 
(4,500  to  5,500  atmospheres)  were  required  to  destroy inhibiting anti-Rh0 
antibodies in  a  "blocking" serum.  This  conforms with ideas  already  held 
that the "blocking" antibodies are significantly more stable than the  agglu- 
tinating antibodies. 
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